Endocrinology Research and Practice
Case Report

A Case Report of Dapagliflozin-Induced Nodular Vasculitis


Department of Endocrinology and Metabolism, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY


Clinic of Endocrinology and Metabolism, Edirne Sultan 1. Murat State Hospital, Edirne, TURKEY


Department of Rheumatology, Necmettin Erbakan University Meram Faculty of Medicine, Konya, TURKEY

Endocrinol Res Pract 2021; 25: 129-132
DOI: 10.25179/tjem.2020-80188
Read: 1510 Downloads: 411 Published: 01 March 2021


Nodular vasculitis (NV), first described by Montgomery in 1945 for erythema induratum-like lesions, is a rare form of panniculitis that is particularly localized on the calves. Characterized by plaques and erythematous nodules, NV may often show ulceration and draining. It is known as a reactive disease associated with many causative factors. Several NV cases due to infectious or non-infectious causative factors have been reported, but no case of NV due to sodium-glucose cotransporter-2 inhibitors (SGLT2i) has yet been reported. In this case report, we presented a case diagnosed with NV, who presented with tender, erythematous, eroded plaques with hemorrhagic-purulent discharge on both legs during treatment with dapagliflozin (an SGLT2i).



EISSN 2822-6135